In August 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results …

Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most
frequent cause of cardiovascular death. The clinical presentation of PE is variable, and …

Treatment strategies for complex patients with pulmonary embolism (PE) are often debated
given patient heterogeneity, multitude of available treatment modalities, and lack of …

Background The impact of pulmonary embolism response teams (PERTs) on treatment
choice and outcomes of patients with acute pulmonary embolism (PE) is still uncertain …

The coexistence of coronavirus disease 2019 (COVID-19) and pulmonary embolism (PE),
two life-threatening illnesses, in the same patient presents a unique challenge. Guidelines …

Background Over the last years, multidisciplinary pulmonary embolism response teams
(PERTs) have emerged to encounter the increasing variety and complexity in the …

Acute pulmonary embolism is the third leading cause of cardiovascular death, with most
pulmonary embolism–related mortality associated with acute right ventricular failure …

Multidisciplinary Pulmonary Embolism Response Teams (PERTs) may improve the care of
patients with a high risk of pulmonary embolism (PE). The impact of a PERT on long-term …

Contemporary data on the national trends in pulmonary embolism (PE) admissions and
outcomes are scarce. We aimed to analyze trends in mortality and different treatment …

Pulmonary embolism (PE) is a major cause of morbidity and mortality in the United States.
Although new therapeutic tools and strategies have recently been developed for the …